Allianz Asset Management
MYGN icon

Allianz Asset Management’s Myriad Genetics MYGN Stock Holding History

Allianz Asset Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,300
Closed -$348K – 2213
2024
Q1 		$348K Sell
16,300
-7,600
-32% -$163K ﹤0.01% 1717
2023
Q4 		$457K Sell
23,900
-1,200
-5% -$20.8K ﹤0.01% 1878
2023
Q3 		$403K Buy
+25,100
New +$478K ﹤0.01% 1997
2023
Q2 		– Sell
-350,014
Closed -$8.13M – 2235
2023
Q1 		$8.13M Buy
350,014
+17,983
+5% +$365K 0.01% 777
2022
Q4 		$4.82M Buy
332,031
+27,100
+9% +$505K 0.01% 926
2022
Q3 		$5.82M Buy
304,931
+102,677
+51% +$2.36M 0.01% 832
2022
Q2 		$3.67M Buy
202,254
+44,111
+28% +$916K ﹤0.01% 1203
2022
Q1 		$3.98M Buy
158,143
+34,591
+28% +$885K ﹤0.01% 1312
2021
Q4 		$3.41M Sell
123,552
-7,900
-6% -$229K ﹤0.01% 1386
2021
Q3 		$4.25M Buy
+131,452
New +$4.37M ﹤0.01% 1345
2020
Q1 		– Sell
-22,243
Closed -$605K – 2669
2019
Q4 		$605K Sell
22,243
-113
-0.5% -$3.11K ﹤0.01% 2379
2019
Q3 		$640K Sell
22,356
-34,377
-61% -$1M ﹤0.01% 2290
2019
Q2 		$1.57M Sell
56,733
-27,627
-33% -$780K ﹤0.01% 1964
2019
Q1 		$2.8M Buy
84,360
+40,584
+93% +$1.24M ﹤0.01% 1709
2018
Q4 		$1.27M Sell
43,776
-101,047
-70% -$3.64M ﹤0.01% 1933
2018
Q3 		$6.66M Sell
144,823
-427,948
-75% -$19M 0.01% 1433
2018
Q2 		$21.4M Sell
572,771
-37,419
-6% -$1.26M 0.02% 840
2018
Q1 		$18M Buy
610,190
+125,172
+26% +$4.24M 0.02% 945
2017
Q4 		$16.7M Buy
485,018
+473,745
+4,202% +$16M 0.01% 1068
2017
Q3 		$408K Buy
11,273
+665
+6% +$19K ﹤0.01% 2461
2017
Q2 		$272K Buy
10,608
+515
+5% +$10.9K ﹤0.01% 2530
2017
Q1 		$194K Sell
10,093
-1,154
-10% -$20.4K ﹤0.01% 2539
2016
Q4 		$187K Hold
11,247
– – ﹤0.01% 2534
2016
Q3 		$233K Sell
11,247
-4,520
-29% -$115K ﹤0.01% 2493
2016
Q2 		$482K Hold
15,767
– – ﹤0.01% 2324
2016
Q1 		$590K Buy
15,767
+4,520
+40% +$170K ﹤0.01% 2223
2015
Q4 		$485K Hold
11,247
– – ﹤0.01% 2199
2015
Q3 		$422K Sell
11,247
-8,445
-43% -$300K ﹤0.01% 2105
2015
Q2 		$669K Sell
19,692
-3,798
-16% -$129K ﹤0.01% 2072
2015
Q1 		$832K Hold
23,490
– – ﹤0.01% 1840
2014
Q4 		$800K Sell
23,490
-3,400
-13% -$121K ﹤0.01% 1877
2014
Q3 		$1.04M Hold
26,890
– – ﹤0.01% 1658
2014
Q2 		$1.05M Sell
26,890
-579
-2% -$21.5K ﹤0.01% 1384
2014
Q1 		$939K Sell
27,469
-36,993
-57% -$1.15M ﹤0.01% 1417
2013
Q4 		$1.35M Buy
64,462
+12,776
+25% +$323K ﹤0.01% 1321
2013
Q3 		$1.22M Sell
51,686
-158,387
-75% -$4.5M ﹤0.01% 1323
2013
Q2 		$5.64M Buy
+210,073
New +$6.09M 0.01% 855

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Allianz Asset Management's MYGN Position: Q2 2024 in Review

Allianz Asset Management sold out of Myriad Genetics (MYGN) in Q2 2024, closing a stake of 16,300 shares — an estimated $348K sold.

Allianz Asset Management first reported a position in MYGN in Q2 2013 and held it in 37 quarters. The position peaked at $21.4M in Q2 2018. 223 funds tracked by Wall St. Rank hold MYGN as of Q2 2024.

  • Allianz Asset Management reported no remaining Myriad Genetics position as of Q2 2024 after selling out during the quarter.
  • Allianz Asset Management sold 16,300 Myriad Genetics shares in Q2 2024, an estimated $348K.
  • Allianz Asset Management first reported a position in Myriad Genetics in Q2 2013 and held it in 37 quarters.
  • Allianz Asset Management's Myriad Genetics position peaked at $21.4M in Q2 2018.
  • 223 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2024.

Based on Allianz Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.